Unleashing Ascl1 : Exploring Cross-Lineage Potential in Reprogramming and Regenerative Frontiers
(2023) In Cellular Reprogramming 25(4). p.139-141- Abstract
In the era of stem cell research and regenerative medicine, understanding the regulatory networks that drive cellular reprogramming is fundamental. The study entitled ‘‘Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes’’ published in Stem Cell Reports sheds light on the remarkable versatility of Ascl1, a transcription factor known for its pivotal role in neurogenesis. By comparing regulatomes across multiple cell lineages, the authors have elucidated the potential of Ascl1 to facilitate the conversion of non-neural cells into various lineages beyond its canonical neural fate, suggesting its potential as a master regulator for lineage reprogramming. These observations challenge our current... (More)
In the era of stem cell research and regenerative medicine, understanding the regulatory networks that drive cellular reprogramming is fundamental. The study entitled ‘‘Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes’’ published in Stem Cell Reports sheds light on the remarkable versatility of Ascl1, a transcription factor known for its pivotal role in neurogenesis. By comparing regulatomes across multiple cell lineages, the authors have elucidated the potential of Ascl1 to facilitate the conversion of non-neural cells into various lineages beyond its canonical neural fate, suggesting its potential as a master regulator for lineage reprogramming. These observations challenge our current understanding of cell fate determination and open exciting avenues for regenerative medicine.
(Less)
- author
- Echegaray, Camila Vazquez LU
- organization
- publishing date
- 2023-08
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Ascl1, direct reprogramming, epigenetics, Mef2c, regulator
- in
- Cellular Reprogramming
- volume
- 25
- issue
- 4
- pages
- 3 pages
- publisher
- Mary Ann Liebert, Inc.
- external identifiers
-
- pmid:37590007
- scopus:85168246176
- ISSN
- 2152-4971
- DOI
- 10.1089/cell.2023.0080
- language
- English
- LU publication?
- yes
- id
- d5451cd8-fbad-40f9-bebc-96fb5e65cc24
- date added to LUP
- 2023-10-31 14:04:00
- date last changed
- 2024-04-19 03:10:00
@article{d5451cd8-fbad-40f9-bebc-96fb5e65cc24, abstract = {{<p>In the era of stem cell research and regenerative medicine, understanding the regulatory networks that drive cellular reprogramming is fundamental. The study entitled ‘‘Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes’’ published in Stem Cell Reports sheds light on the remarkable versatility of Ascl1, a transcription factor known for its pivotal role in neurogenesis. By comparing regulatomes across multiple cell lineages, the authors have elucidated the potential of Ascl1 to facilitate the conversion of non-neural cells into various lineages beyond its canonical neural fate, suggesting its potential as a master regulator for lineage reprogramming. These observations challenge our current understanding of cell fate determination and open exciting avenues for regenerative medicine.</p>}}, author = {{Echegaray, Camila Vazquez}}, issn = {{2152-4971}}, keywords = {{Ascl1; direct reprogramming; epigenetics; Mef2c; regulator}}, language = {{eng}}, number = {{4}}, pages = {{139--141}}, publisher = {{Mary Ann Liebert, Inc.}}, series = {{Cellular Reprogramming}}, title = {{Unleashing Ascl1 : Exploring Cross-Lineage Potential in Reprogramming and Regenerative Frontiers}}, url = {{http://dx.doi.org/10.1089/cell.2023.0080}}, doi = {{10.1089/cell.2023.0080}}, volume = {{25}}, year = {{2023}}, }